SARS-CoV-2 infection in patients with inflammatory bowel disease in the second-third wave and its comparison with data of first wave of pandemic

Algaba, Alicia; Guerra, Iván; Castro, Sofía; Bermejo, Fernando

doi:10.1016/j.gastre.2022.07.002

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 1 We also recently reported on how the incidence of COVID-19 had evolved in our patients in the 2nd and 3rd waves. 2 In a joint communication with the patients’ Asociaciones de Crohn y Colitis Ulcerosa (ACCU) [Crohn’s and Ulcerative Colitis Associations) and the Grupo Enfermero de Trabajo en Enfermedad Inflamatoria Intestinal (GETEII) [Nursing Working Group on Inflammatory Bowel Disease]), the Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU) [Spanish Working Group on Crohn’s Disease and Ulcerative Colitis] explains that the vaccine is safe in patients with IBD. 3 There is no evidence to suggest an increased risk in other immune-based diseases or patients on steroid, immunosuppressive or biological treatment.…”

Section: Introductionmentioning

confidence: 99%